Categories AlphaGraphs, Earnings, Health Care
AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced fourth-quarter 2024 financial results, reporting a double-digit dip in adjusted earnings and an increase in revenues.
The company reported worldwide net revenues of $15.1 billion for the December quarter, up 6% from the corresponding period of 2023. The main operating segments registered growth.
Net income, adjusted for special items, declined to $2.16 per share in Q4 from $2.79 per share in the year-ago quarter. On a reported basis, it was a net loss of $22 million or $0.02 per share in the fourth quarter, compared to a profit of $822 million or $0.46 per share last year.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
ADSK Earnings: Highlights of Autodesk’s Q4 2025 report
Autodesk, Inc. (NASDAQ: ADSK) has reported a double-digit increase in revenues and adjusted earnings for the fourth quarter of 2025 amid strong demand for its products. The design software company’s
Monster Beverage (MNST) Earnings: 4Q24 Key Numbers
Monster Beverage Corporation (NASDAQ: MNST) reported its earnings results for the fourth quarter of 2024. Net sales increased 4.7% year-over-year to $1.81 billion. Net sales on a foreign currency adjusted
HPQ Q1 Call Highlights: AI PC Adoption, Supply Chain Resilience and Subscription Milestones!
HP Inc., a leading provider of computers, printers, and printer supplies, in its Q1 earnings call discusses about the comprehensive picture of their current business strategy and market positioning. The
